Your browser doesn't support javascript.
loading
Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app.
Bousquet, J; Sousa-Pinto, B; Anto, J M; Amaral, R; Brussino, L; Canonica, G W; Cruz, A A; Gemicioglu, B; Haahtela, T; Kupczyk, M; Kvedariene, V; Larenas-Linnemann, D E; Louis, R; Pham-Thi, N; Puggioni, F; Regateiro, F S; Romantowski, J; Sastre, J; Scichilone, N; Taborda-Barata, L; Ventura, M T; Agache, I; Bedbrook, A; Bergmann, K C; Bosnic-Anticevich, S; Bonini, M; Boulet, L-P; Brusselle, G; Buhl, R; Cecchi, L; Charpin, D; Chaves-Loureiro, C; Czarlewski, W; de Blay, F; Devillier, P; Joos, G; Jutel, M; Klimek, L; Kuna, P; Laune, D; Pech, J L; Makela, M; Morais-Almeida, M; Nadif, R; Niedoszytko, M; Ohta, K; Papadopoulos, N G; Papi, A; Yeverino, D R; Roche, N.
Afiliación
  • Bousquet J; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany; University Hospital Mo
  • Sousa-Pinto B; MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences; Faculty of Medicine, University of Porto, Porto, Portugal; CINTESIS - Center for Health Technology and Services Research; University of Porto, Porto, Portugal; RISE - Health Research Network; University of Porto, P
  • Anto JM; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
  • Amaral R; MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences; Faculty of Medicine, University of Porto, Porto, Portugal; CINTESIS - Center for Health Technology and Services Research; University of Porto, Porto, Portugal; RISE - Health Research Network; University of Porto, P
  • Brussino L; Department of Medical Sciences, Allergy and Clinical Immunology Unit, University of Torino & Mauriziano Hospital, Torino, Italy.
  • Canonica GW; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center IRCCS, Rozzano, Italy.
  • Cruz AA; Fundaçao ProAR, Federal University of Bahia and GARD/WHO Planning Group, Salvador, Bahia, Brazil.
  • Gemicioglu B; Department of Pulmonary Diseases, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Turkey.
  • Haahtela T; Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Finland.
  • Kupczyk M; Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Poland.
  • Kvedariene V; Institute of Clinical medicine, Clinic of Chest diseases and Allergology, Faculty of Medicine, Vilnius University and Institute of Biomedical Sciences, Department of Pathology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Larenas-Linnemann DE; Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico.
  • Louis R; Department of Pulmonary Medicine, CHU Liège and GIGA I3 research group, University of Liege, Belgium.
  • Pham-Thi N; Ecole Polytechnique Palaiseau, IRBA (Institut de Recherche bio-Médicale des Armées), Bretigny, France.
  • Puggioni F; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center IRCCS, Rozzano, Italy.
  • Regateiro FS; Allergy and Clinical Immunology Unit, Centro Hospitalar e Universitário de Coimbra, and Coimbra Institute for Clinical and Biomedical Research (ICBR), Faculty of Medicine, University of Coimbra, and Institute of Immunology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Romantowski J; Department of Allergology, Medical University of Gdansk, Gdansk, Poland.
  • Sastre J; Fundacion Jimenez Diaz, CIBERES, Faculty of Medicine, Autonoma University of Madrid, Spain.
  • Scichilone N; PROMISE Department, University of Palermo, Palermo, Italy.
  • Taborda-Barata L; Department of Immunoallergology, Cova da Beira University Hospital Centre, Covilhã, and UBIAir - Clinical & Experimental Lung Centre, and CICS-UBI Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.
  • Ventura MT; Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.
  • Agache I; Transylvania University Brasov, Brasov, Romania.
  • Bedbrook A; ARIA, Montpellier, France.
  • Bergmann KC; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
  • Bosnic-Anticevich S; Quality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, The University of Sydney, and Sydney Local Health District, Sydney, NSW, Australia.
  • Bonini M; Department of Cardiovascular and Thoracic Sciences, Università Cattolica del Sacro Cuore, Rome, Italy; Department of Clinical and Surgical Sciences, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy; National Heart and Lung Institute, Royal Brompton Hospital & Imperial College Lo
  • Boulet LP; Quebec Heart and Lung Institute, Laval University, Québec City, Quebec, Canada.
  • Brusselle G; Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
  • Buhl R; Dept of Pulmonary Medicine, Mainz University Hospital, Mainz, Germany.
  • Cecchi L; SOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy.
  • Charpin D; Clinique des bronches, allergie et sommeil, Hôpital Nord, Marseille, France.
  • Chaves-Loureiro C; Pneumology Unit, Hospitais da Universidade de Coimbra, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
  • Czarlewski W; Medical Consulting Czarlewski, Levallois, France.
  • de Blay F; Allergy Division, Chest Disease Department, University Hospital of Strasbourg, and Federation of translational medicine, University of Strasbourg, Strasbourg, France.
  • Devillier P; VIM Suresnes, UMR 0892, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France.
  • Joos G; Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
  • Jutel M; Department of Clinical Immunology, Wroclaw Medical University, and ALL-MED Medical Research Institute, Wroclaw, Poland.
  • Klimek L; Department of Otolaryngology, Head and Neck Surgery, Universitätsmedizin Mainz, Mainz, and Center for Rhinology and Allergology, Wiesbaden, Germany.
  • Kuna P; Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Poland.
  • Laune D; KYomed INNOV, Montpellier, France.
  • Pech JL; University of Guadalajara, Guadalajara, Mexico.
  • Makela M; Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Finland.
  • Morais-Almeida M; Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal.
  • Nadif R; Université Paris-Saclay, UVSQ, Univ. Paris-Sud, and Inserm, Equipe d'Epidémiologie Respiratoire Intégrative, CESP, Villejuif, France.
  • Niedoszytko M; Department of Allergology, Medical University of Gdansk, Gdansk, Poland.
  • Ohta K; National Hospital Organization, Tokyo National Hospital, and JATA Fukujuji Hospital, Tokyo, Japan.
  • Papadopoulos NG; Allergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece.
  • Papi A; Respiratory Medicine, Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
  • Yeverino DR; Allergy and Clinical Immunology Department, Hospital Universitario de Puebla, Puebla, Mexico.
  • Roche N; Pneumologie, AP-HP Centre Université de Paris Cité, Hôpital Cochin, Paris and UMR 1016, Institut Cochin, Paris, France.
Pulmonology ; 29(4): 292-305, 2023.
Article en En | MEDLINE | ID: mdl-36428213
ABSTRACT

BACKGROUND:

The self-reporting of asthma frequently leads to patient misidentification in epidemiological studies. Strategies combining the triangulation of data sources may help to improve the identification of people with asthma. We aimed to combine information from the self-reporting of asthma, medication use and symptoms to identify asthma patterns in the users of an mHealth app.

METHODS:

We studied MASK-air® users who reported their daily asthma symptoms (assessed by a 0-100 visual analogue scale - "VAS Asthma") at least three times (either in three different months or in any period). K-means cluster analysis methods were applied to identify asthma patterns based on (i) whether the user self-reported asthma; (ii) whether the user reported asthma medication use and (iii) VAS asthma. Clusters were compared by the number of medications used, VAS asthma levels and Control of Asthma and Allergic Rhinitis Test (CARAT) levels.

FINDINGS:

We assessed a total of 8,075 MASK-air® users. The main clustering approach resulted in the identification of seven groups. These groups were interpreted as probable (i) severe/uncontrolled asthma despite treatment (11.9-16.1% of MASK-air® users); (ii) treated and partly-controlled asthma (6.3-9.7%); (iii) treated and controlled asthma (4.6-5.5%); (iv) untreated uncontrolled asthma (18.2-20.5%); (v) untreated partly-controlled asthma (10.1-10.7%); (vi) untreated controlled asthma (6.7-8.5%) and (vii) no evidence of asthma (33.0-40.2%). This classification was validated in a study of 192 patients enrolled by physicians.

INTERPRETATION:

We identified seven profiles based on the probability of having asthma and on its level of control. mHealth tools are hypothesis-generating and complement classical epidemiological approaches in identifying patients with asthma.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma / Aplicaciones Móviles / Rinitis Alérgica Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Pulmonology Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma / Aplicaciones Móviles / Rinitis Alérgica Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Pulmonology Año: 2023 Tipo del documento: Article